COVID-19 Emergency Medical Supplies Enhancement Act of 2021
Summary
COVID-19 Emergency Medical Supplies Enhancement Act of 2021 This bill expands certain authorities under the Defense Production Act of 1950 (DPA) and authorizes the President and federal agencies to take specific actions to support the production of critical medical supplies during the COVID-19 (i.e., coronavirus disease 2019) emergency, including with respect to private-sector coordination, needs assessments, and overall strategies. The bill makes loans under the DPA subject to certain notification requirements. A report required under the DPA for FY2022 and FY2023 shall include the percentage of contracts awarded to small businesses.
Bill status
passed
3 of 5 stages cleared
Introduction
May 2021
Committee Review
May 2021
House Passage
May 2021
Senate Passage
President
Introduced May 11, 2021
Last action May 19, 2021
Floor votes
How they voted
This bill passed the House by voice vote (no roll call recorded).
Full legislative history
Actions timeline
Total actions
9
Key actions
1
Committee
2
May 19, 2021
Committee
Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
upper
May 18, 2021
Lower · Passed
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H2456-2457)
lower
May 11, 2021
Committee
Referred to the House Committee on Financial Services.
lower
May 11, 2021
Introduced
Introduced in House
lower
1 primary · 4 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 3125
Scope: US
Hi! I can help you understand HR 3125. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline